ArticleBMC biology2026
Peptide language pragmatic analysis and two-stage hierarchical learning framework for therapeutic peptide prediction.
Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTherapeutic peptides exert pivotal effects in diverse biological processes, and have attracted significant interest in the field of biomedicine in recent years. However, most existing methods often fail to adequately capture the intricate interactions among amino acid residues and the contextual dependencies within peptide sequences, which hampers the extraction of deep semantic representations and ultimately restricts predictive performance. Moreover, the task of multi-functional therapeutic peptide prediction is inherently constrained by the challenge of imbalanced multi-label classification resulting from long-tailed distribution patterns.
resultsIn this study, we propose a two-stage hierarchical deep learning framework, named TPpred-PepPA, for the prediction of multi-functional therapeutic peptides based on pragmatic analysis. Specifically, ProtT5 is employed to extract deep semantic representations that capture residue-level contextual information. In the first stage, a transformer-based network is utilized to perform shared representation learning, wherein the encoder model captures the intricate inter-residue interaction to characterize the contextual semantics of peptide sequences. In the second stage, the framework is fine-tuned by incorporating task-specific classifiers and optimizing the classification decision with Asymmetric Loss. Then the dynamic thresholding strategy is utilized to address the long-tail distribution problem, enabling more accurate prediction performance of multi-functional therapeutic peptide. Moreover, we adopted the SHAP analysis and motif identification to interpret feature contributions and identify key functional peptide fragments, respectively. Our experimental results indicate that TPpred-PepPA significantly outperforms all current baseline methods in identifying multi-functional therapeutic peptides and exhibits robust performance in recognizing rare functional categories.
conclusionWe developed TPpred-PepPA, a two-stage hierarchical deep learning framework based on the ProtT5 pre-trained large language model. Compared with existing methods, TPpred-PepPA achieves state-of-the-art predictive performance and provides valuable interpretability for the discovery of multi-functional therapeutic peptides. Finally, a web server has been established and is accessible at http://bliulab.net/TPpred-PepPA .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.